Stock Events

Stock Events

Medicinova 

$1.3500
19
+$0.01+0.75% 12:43 Today

Statistics

Day High
1.345
Day Low
1.345
52W High
1.96
52W Low
1.17
Volume
864
Avg. Volume
-
Mkt Cap
65.96M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.14
-0.11
-0.08
-0.05
Expected EPS
-0.063333
Actual EPS
N/A

Financials

-2,926.34%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
410,000Revenue
-12MNet Income

Analyst Ratings

8.33Average Price Target
The highest estimate is 10.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MNOV. It's not an investment recommendation.
Amazon
4
AMZN
Ford Motor
4
F
Tesla
3
TSLA
Alphabet
3
GOOGL

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap31B
Biogen focuses on neurology, a key area for Medicinova, making them direct competitors in the development of treatments for neurological disorders.
Novartis
NVS
Mkt Cap286.78B
Novartis has a broad portfolio in neuroscience and innovative medicines, competing with Medicinova in multiple sclerosis and other neurological conditions.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences has expanded into the treatment of neurological disorders, positioning it as a competitor to Medicinova in this therapeutic area.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.85B
Teva Pharmaceutical specializes in generic and specialty medicines, including treatments for neurological conditions, directly competing with Medicinova.
AMGEN
AMGN
Mkt Cap224.63B
Amgen's focus on innovative therapeutics includes work in neurology, making it a competitor in the space Medicinova operates in.
Pfizer
PFE
Mkt Cap152.69B
Pfizer has a diverse portfolio that includes treatments for neurological disorders, competing with Medicinova in research and development of new medicines.
Merck
MRK
Mkt Cap335.14B
Merck operates in various therapeutic areas, including neurology, competing with Medicinova in the development of treatments for neurological diseases.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca has a growing focus on neurological disorders, making it a competitor to Medicinova in the development of treatments for these conditions.
Lilly(Eli) &
LLY
Mkt Cap1.05T
Eli Lilly has a strong emphasis on neuroscience, including Alzheimer's disease, which competes with Medicinova's focus on neurological disorders.

About

MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
Show more...
CEO
Yuichi Iwaki
Employees
6
Country
United States
ISIN
US58468P2065

Listings

STU
DE
RMN.STU
XNAS
US
MNOV
TSE
JP
4875.TSE
BOATS
BOATS
MNOV.BOATS

0 Comments

Share your thoughts

FAQ

What is Medicinova stock price today?▼
The current price of MNOV is $1.35 USD — it has increased by +0.75% in the past 24 hours. Watch Medicinova stock price performance more closely on the chart.
What is Medicinova stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Medicinova stocks are traded under the ticker MNOV.
Is Medicinova stock price growing?▼
MNOV stock has risen by +0.75% compared to the previous week, the month change is a -0.74% fall, over the last year Medicinova has showed a +3.08% increase.
What is Medicinova market cap?▼
Today Medicinova has the market capitalization of 65.96M
When is the next Medicinova earnings date?▼
Medicinova is going to release the next earnings report on November 12, 2026.
What were Medicinova earnings last quarter?▼
MNOV earnings for the last quarter are -0.05 USD per share, whereas the estimation was -0.06 USD resulting in a +28.95% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Medicinova revenue for the last year?▼
Medicinova revenue for the last year amounts to 410,000 USD.
What is Medicinova net income for the last year?▼
MNOV net income for the last year is -12M USD.
How many employees does Medicinova have?▼
As of August 19, 2026, the company has 6 employees.
In which sector is Medicinova located?▼
Medicinova operates in the Health & Wellness sector.
When did Medicinova complete a stock split?▼
The last stock split for Medicinova was on November 02, 2006 with a ratio of 1:10.
Where is Medicinova headquartered?▼
Medicinova is headquartered in LA JOLLA, United States.